Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104295
Filing Date
2025-08-07
Accepted
2025-08-06 17:53:50
Documents
72
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-20250630.htm   iXBRL 10-Q 2334333
2 EX-10.2 acad-ex10_2.htm EX-10.2 804535
3 EX-10.3 acad-ex10_3.htm EX-10.3 45036
4 EX-10.4 acad-ex10_4.htm EX-10.4 129342
5 EX-10.5 acad-ex10_5.htm EX-10.5 187908
6 EX-31.1 acad-ex31_1.htm EX-31.1 11763
7 EX-31.2 acad-ex31_2.htm EX-31.2 11919
8 EX-32.1 acad-ex32_1.htm EX-32.1 8557
9 EX-32.2 acad-ex32_2.htm EX-32.2 8603
10 GRAPHIC img92781250_0.jpg GRAPHIC 423958
  Complete submission text file 0000950170-25-104295.txt   11203030

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20250630.xsd EX-101.SCH 975376
75 EXTRACTED XBRL INSTANCE DOCUMENT acad-20250630_htm.xml XML 1933717
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 251190886
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)